Physiomics secures two new contracts, names head of biometrics unit.


Data science and biostatistics company Physiomics said on Monday that it had secured two new contracts with a UK-headquartered clinical-stage biopharmaceutical company.

Physiomics

Source: Sharecast

Physiomics said the contracts, its first-ever biometrics awards, would see it aid the biopharmaceutical firm in developing immunotherapies that target a range of diseases.

In support of two of the client's active clinical programmes, Physiomics will provide biostatistical consulting and statistical programming services starting in July 2025 and continuing over an initial period of one year.

The AIM-listed group stated the combined value of both contracts was estimated to be roughly £111,000.

Separately, Physiomics announced that Jesse Thissen would take over as head of its biometrics unit, effective 1 July.

"Bringing in these initial two new contracts, the head of Biometrics will be responsible for delivering them and will be instrumental in supporting the company further expand its biometrics offering and driving revenue growth in this new area for Physiomics," said the group.

As of 1125 BST, Physiomics shares were up 9.24% at 0.50p.

Reporting by Iain Gilbert at Sharecast.com


ISIN: GB00BDR6W943
Exchange: London Stock Exchange
Sell:
0.45 p
Buy:
0.55 p
Change: 0.00 ( 0.00 %)
Date:
Prices delayed by at least 15 minutes

Compare our accounts

If you're looking to grow your money over the longer term (5+ years), we have a range of investment choices to help.

Halifax is not responsible for the content and accuracy of the Markets News articles. We may not share the views of the author. Understand the risks, please remember the value of your investment can go down as well as up and you may not get back the full amount you invest. We don't provide advice so if you are in any doubt about buying and selling shares or making your own investment decisions we recommend you seek advice from a suitably qualified Financial Advisor. Past performance is not a guide to future performance.